RPS6KL1
Summary:
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| ribosomal protein S6 kinase like 1 | Ensembl:ENSG00000198208 | HGNC:HGNC:20222 | PA134868364 | 14q24.3 |
GO terms in RPS6KL1
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| MF | IEA | GO:0004674 | protein serine/threonine kinase activity |
| MF | IEA | GO:0005524 | ATP binding |
| CC | IEA | GO:0005840 | ribosome |
| BP | IEA | GO:0006468 | protein phosphorylation |
Gene expression in normal tissue: RPS6KL1
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in RPS6KL1
| Database | Pathway ID | Pathway Des. |
|---|
Gene-Drug: Aster Plot
| Drug ID | Drug Name | Model Num. |
|---|---|---|
| iGMDRD330 | BRD4132 | 3 |
| iGMDRD579 | PF750 | 3 |
| iGMDRD248 | BRD4354 | 3 |
| iGMDRD427 | ABT737 | 6 |
| iGMDRD483 | SCH-529074 | 2 |
| iGMDRD494 | Neopeltolide | 3 |
| iGMDRD79 | Gemcitabine | 3 |
| iGMDRD123 | Isoevodiamine | 3 |
| iGMDRD466 | Chaetocin | 6 |
| iGMDRD375 | GW-405833 | 3 |
| iGMDRD103 | SN-38 | 3 |
| iGMDRD221 | Tamoxifen | 3 |
| iGMDRD105 | Triptolide | 3 |
| iGMDRD782 | DC-45-A2 | 3 |
| iGMDRD441 | TW 37 | 3 |
| iGMDRD231 | Importazole | 3 |
| iGMDRD267 | Oligomycin A | 1 |
| iGMDRD77 | Itraconazole | 6 |
| iGMDRD52 | Rotenone | 3 |
| iGMDRD887 | Compound 23 citrate | 3 |
| iGMDRD506 | Fedratinib | 3 |
| iGMDRD329 | Merck60 | 3 |
| iGMDRD577 | BIX01294 | 6 |
| iGMDRD888 | Compound 44 | 4 |
| iGMDRD562 | Navitoclax | 6 |
| iGMDRD269 | Purmorphamine | 1 |
| iGMDRD60 | Quinoclamine | 1 |
| iGMDRD23 | Gossypol | 3 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in RPS6KL1
CLASSFICATION
Copyright © 2018 Modellab | All Rights Reserved
Disclaimer: iGMDR is intended for research purposes only. Its information cannot be used for emergencies or medical or professional advice.